XNAS · CDT
-7.11% · -$0.0314 · Vol 314.3K
After hours · updated 17:16:53 ET
CDT Equity Inc. Common Stock

CDT Equity Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.4104

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is CDT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About CDT Equity Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2023
Employees
4
Country
US

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.4380
Day high
$0.4380
Day low
$0.3850
Previous close
$0.4418
52W high
$1.42
-71.10% from high
52W low
$0.3850
2% of range
Market cap
$2.1M
EPS
$-20.0100
Shares out
4.9M
Volume
314.3K
VWAP
$0.4008
Price history computed in-house
1W
-14.07%
1M
-44.14%
SMA 50 $0.7016 · below
SMA 200 $0.7016 · below
52W position 2%
Veridion warehouse edge

Warehouse intelligence for CDT.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

CDT insider activity

CDT Equity Inc. Common Stock

Score
Coverage building
Pressure
Net buying
Filings
11
Buys / sells
7 / 4
Net value
$445K
Insiders
4
Named filers
TA
Taylor Mark Andrew
Insider
Leadership
RA
Regan Andrew
Insider
Leadership
FC
Farley Chele Chiavacci
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net buying: $445K across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-232026-06-18Taylor Mark AndrewInsidersell$1.40593,289Not reported$829KSEC Form 4
2026-06-232026-06-18Taylor Mark AndrewInsidersell$0.755,000593,289$4KSEC Form 4
2026-06-232026-06-18Taylor Mark AndrewInsidersell$1.441,464,711Not reported$2.1MSEC Form 4
2026-06-232026-06-18Taylor Mark AndrewInsidersell$0.715,0001,464,711$4KSEC Form 4
2026-05-142026-05-13Regan AndrewInsiderbuy$1.90100,000256,393$190KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 6 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

CDT contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CDT in this window.
Lobbying spend

CDT lobbying filings, year to date.

Registered lobbying filings matched to CDT Equity Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CDT in this window.
Latest news · CDT
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for CDT.
Options
Sovereign unlock shows live options positioning for CDT.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.